Multiple Opportunities with Layered Revenue Horizons
SGN NanoPharma, a Florida, USA Corp., is a cutting edge, clinical-stage, revenue generating, nanotherapeutics company that combines proprietary nanotechnologies with structural biology to generate superior medicine.
We intend to be a leading global nanomedicine company. We have developed near term and global strategies to achieve that goal.
Our near term focus is to:
(a) formulate Cannabinoids to generate ophthalmic, neural and transdermal formulations to address large unmet medical needs and,
(b) reformulate underperforming FDA approved drugs that are sub-optimal due to poor water solubility and low bioavailability.
A key component of our strategy and focus is to generate revenues via MNP Technology-based products in India and related emerging markets from the outset, while conducting proof-of-concept (POC) clinical trials for US and other regulated markets in low-cost geographies such as India.